These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3741520)
1. Successful treatment of Raynaud's phenomenon with pentoxifylline. Goldberg J; Dlesk A Arthritis Rheum; 1986 Aug; 29(8):1055-6. PubMed ID: 3741520 [No Abstract] [Full Text] [Related]
2. [Hemorheological, hemocoagulation and photoplethysmographic changes induced by the administration of pentoxifylline in patients with Raynaud's disease]. Macchione C; Molaschi M; Neirotti M; Garrone MT; Longo F; Pernigotti L Minerva Med; 1985 Jul; 76(30-31):1401-5. PubMed ID: 4022431 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of ketanserin and pentoxiphylline in treatment of Raynaud's phenomenon. Arosio E; Montesi G; Zannoni M; Paluani F; Lechi A Angiology; 1989 Jul; 40(7):633-8. PubMed ID: 2662829 [TBL] [Abstract][Full Text] [Related]
4. Functional vascular disorders: treatment with pentoxifylline. Neirotti M; Longo F; Molaschi M; Macchione C; Pernigotti L Angiology; 1987 Aug; 38(8):575-80. PubMed ID: 3631642 [TBL] [Abstract][Full Text] [Related]
5. Treatment of peripheral gangrene due to systemic sclerosis with intravenous pentoxifylline. Goodfield MJ; Rowell NR Clin Exp Dermatol; 1989 Mar; 14(2):161-2. PubMed ID: 2598492 [TBL] [Abstract][Full Text] [Related]
6. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs]. Runge E; Thiele P Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of Raynaud's phenomenon. Belch JJ; Ho M Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818 [TBL] [Abstract][Full Text] [Related]
8. [Clinical study of the cerebrovascular action of pentoxifylline]. Shtok VN; Fedorova NV; Gadanova IV Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):60-6. PubMed ID: 7064607 [TBL] [Abstract][Full Text] [Related]
9. Oral L-arginine can reverse digital necrosis in Raynaud's phenomenon. Rembold CM; Ayers CR Mol Cell Biochem; 2003 Feb; 244(1-2):139-41. PubMed ID: 12701823 [TBL] [Abstract][Full Text] [Related]
10. Managing Raynaud's phenomenon: a practical approach. Adee AC Am Fam Physician; 1993 Mar; 47(4):823-9. PubMed ID: 8438681 [TBL] [Abstract][Full Text] [Related]
11. Treatment of the Raynaud's phenomenon with piracetam. Moriau M; Lavenne-Pardonge E; Crasborn L; von Frenckell R; Col-Debeys C Arzneimittelforschung; 1993 May; 43(5):526-35. PubMed ID: 8328997 [TBL] [Abstract][Full Text] [Related]
12. Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment. Zhao H; Lian Y Australas J Dermatol; 2015 Aug; 56(3):202-5. PubMed ID: 25817568 [TBL] [Abstract][Full Text] [Related]
13. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon. Kahan A; Amor B; Menkes CJ Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061 [TBL] [Abstract][Full Text] [Related]
14. CysLT1 receptor inhibition in patients with Raynaud's phenomenon: capillaroscopic evidence of the role of leukotriene. Azevedo MN; Bernardini EM; Salles EF; Heinzmann F; Marconde F; Mello T; Gomes BE Rev Bras Reumatol; 2012; 52(1):30-2. PubMed ID: 22286643 [TBL] [Abstract][Full Text] [Related]
19. Treatment of ischemic leg ulcers with pentoxifylline: a case report and theoretical considerations. Velanovich V; Fahey MJ Ann Plast Surg; 1990 Jul; 25(1):58-62. PubMed ID: 2378498 [TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline and vascular disease. Spittell JA Ration Drug Ther; 1986 Nov; 20(11):4-6. PubMed ID: 3588935 [No Abstract] [Full Text] [Related] [Next] [New Search]